Connection
Mark Lovell to Enzyme-Linked Immunosorbent Assay
This is a "connection" page, showing publications Mark Lovell has written about Enzyme-Linked Immunosorbent Assay.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.218 |
|
|
|
-
Lovell MA, Abner E, Kryscio R, Xu L, Fister SX, Lynn BC. Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production. Oxid Med Cell Longev. 2015; 2015:787805.
Score: 0.101
-
Bradley-Whitman MA, Abner E, Lynn BC, Lovell MA. A Novel Plasma Based Biomarker of Alzheimer's Disease. J Alzheimers Dis. 2015; 47(3):761-71.
Score: 0.098
-
Weidner AM, Bradley MA, Beckett TL, Niedowicz DM, Dowling AL, Matveev SV, LeVine H, Lovell MA, Murphy MP. RNA oxidation adducts 8-OHG and 8-OHA change with A?42 levels in late-stage Alzheimer's disease. PLoS One. 2011; 6(9):e24930.
Score: 0.019